The HIV Epidemic in Sub-Saharan Africa is Aging: Evidence from the Demographic and Health Surveys in Sub-Saharan Africa

AIDS and Behavior

Volumn 21, Issue , 2017, Pages 101-113

  Vollmer, Sebastian ^a,b   Harttgen, Kenneth ^c   Alfven, Tobias ^d   Padayachy, Jude ^d   Ghys, Peter ^d   Bärnighausen, Till ^b,e,f  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c ETH ZURICH   (Switzerland)

^d UNAIDS   (Switzerland)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aging; HIV; Sub Saharan Africa

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; AGED; AGING; EPIDEMIC; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; AGED; AGING; EPIDEMICS; FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; YOUNG ADULT;

EID: 84994764981     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-016-1591-7     Document Type: Article

References (42)

1. Mills EJ, Bärnighausen T, Negin J. HIV and aging–preparing for the challenges ahead. New Engl J Med. 2012;366(14):1270–3.
2. Negin J, Bärnighausen T, Lundgren JD, Mills EJ. Aging with HIV in Africa: the challenges of living longer. AIDS. 2012;26(Suppl 1):S1–5.
3. UNAIDS. UNAIDS report on the global AIDS epidemic. Geneva: UNAIDS; 2013.
4. Zaidi J, Grapsa E, Tanser F, Newell ML, Bärnighausen T. Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS. 2013;27(14):2301–5.
5. Bärnighausen T, Tanser F, Newell ML. Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res Hum Retroviruses. 2009;25(4):405–9.
6. Bärnighausen T, Wallrauch C, Welte A, et al. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS ONE. 2008;3(11):e3640.
7. Asamoah-Odei E, Garcia Calleja JM, Boerma JT. HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences. Lancet. 2004;364(9428):35–40.
8. Boerma JT, Ghys PD, Walker N. Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet. 2003;362(9399):1929–31.
9. Garcia-Calleja JM, Gouws E, Ghys PD. National population based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates. Sexual Transm Infect. 2006;82(Suppl 3):64–70.
10. ICF International. Prevalence estimates from the demographic and health surveys. Calverton: ICF International; 2012.
11. Braunstein SL, van de Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev. 2009;11(3):140–56.
12. Misiri HE, Edriss A, Aalen OO, Dahl FA. Estimation of HIV incidence in Malawi from cross-sectional population-based sero-prevalence data. J Int AIDS Soc. 2012;15(1):14.
13. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ. 2010;88(11):847–53.
14. Wallrauch C, Bärnighausen T, Newell ML. HIV prevalence and incidence in people 50 years and older in rural South Africa. S Afr Med J. 2010;100(12):812–4.
15. Gomez-Olive FX, Angotti N, Houle B, et al. Prevalence of HIV among those 15 and older in rural South Africa. AIDS Care. 2013;25(9):1122–8.
16. Harling G, Newell ML, Tanser F, Bärnighausen T. Partner age-disparity and HIV incidence risk for older women in rural South Africa. AIDS Behav. 2015;19(7):1317–26.
17. Harling G, Newell ML, Tanser F, Kawachi I, Subramanian SV, Bärnighausen T. Do age-disparate relationships drive HIV incidence in young women? Evidence from a population cohort in rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2014;66(4):443–51.
18. Nicolosi A, Buvat J, Glasser DB, Hartmann U, Laumann EO, Gingell C. Sexual behaviour, sexual dysfunctions and related help seeking patterns in middle-aged and elderly Europeans: the global study of sexual attitudes and behaviors. World J Urol. 2006;24(4):423–8.
19. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64(5):991–7.
20. Diokno AC, Brown MB, Herzog AR. Sexual function in the elderly. Arch Intern Med. 1990;150(1):197–200.
21. Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. New Engl J Med. 2007;357(8):762–74.
22. Lovejoy TI, Heckman TG, Sikkema KJ, Hansen NB, Kochman A. Changes in sexual behavior of HIV-infected older adults enrolled in a clinical trial of standalone group psychotherapies targeting depression. AIDS Behav. 2015;19(1):1–8.
23. Lovejoy TI, Heckman TG, Sikkema KJ, et al. Patterns and correlates of sexual activity and condom use behavior in persons 50-plus years of age living with HIV/AIDS. AIDS Behav. 2008;12(6):943–56.
24. Bärnighausen T, Biraro S, Bwanika J, et al. Diverse age patterns of HIV incidence rates in Africa. In: XVII International AIDS Conference, 3–8 August 2008, Mexico City; 2008.
25. Bor J, Herbst AJ, Newell ML, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961–5.
26. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155(4):209–16.
27. Hontelez JA, de Vlas SJ, Baltussen R, et al. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS. 2012;26(Suppl 1):S19–30.
28. Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;102(8):1516–26.
29. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.
30. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365(6):493–505.
31. Vollmer S, Alfven T, Padayachy J, Harttgen K, Ghys PD, Bärnighausen. T. HIV surveys in older adults: better data, better health. Lancet HIV. 2015; 2:e40–e41.
32. WHO/UNICEF/UNAIDS. Global update on HIV treatment 2013. WHO: Geneva; 2013.
33. Mills EJ, Rammohan A, Awofeso N. Ageing faster with AIDS in Africa. Lancet. 2011;377(9772):1131–3.
34. Justice AC. Commentary: treated HIV infection is a chronic disease: the case against cause of death analyses. Int J Epidemiol. 2010;39(1):146–8.
35. Bärnighausen T, Welz T, Hosegood V, et al. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens. 2008;22(3):236–9.
36. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44(12):1625–31.
37. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metabol. 2007;92(7):2506–12.
38. Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012;60(4):351–8.
39. De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 2008;31(6):1224–9.
40. Guimaraes MM, Greco DB, Figueiredo SM, Foscolo RB, Oliveira AR Jr, Machado LJ. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection. Atherosclerosis. 2008;201(2):434–9.
41. De Luca A, de Gaetano Donati K, Colafigli M, et al. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study. BMC Infect Dis. 2013;13:414.
42. Cohen B, Menken J. Aging in sub-Saharan Africa: recommendation for futhering research. Washington, DC: National Academy of Sciences; 2006.